443
Last Update Posted: 2005-06-24
Recruiting has ended
All Genders accepted | 25 Years-60 Years |
Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Ondansetron Treatment for Alcoholism
The purpose of this study is to: a) evaluate the effectiveness of ondansetron (Zofran) in the treatment of alcohol dependent patients; b) investigate whether early versus late onset alcoholism predicts treatment outcome; and c) determine whether the early and late onset groups respond differently to treatment. Individuals will be "typed" into early onset and late onset alcoholism groups. Individuals will be randomly assigned to a 12-week outpatient treatment program.
Eligibility
Relevant conditions:
Alcoholism
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
Inclusion criteria
Exclusion criteria
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov